ProtoKinetix, Incorporated (PKTX)
OTCMKTS · Delayed Price · Currency is USD
0.0077
0.00 (0.00%)
Mar 25, 2026, 9:30 AM EST
ProtoKinetix Market Cap
ProtoKinetix has a market cap or net worth of $3.15 million as of March 26, 2026. Its market cap has decreased by -5.52% in one year.
Market Cap
3.15M
Enterprise Value
3.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 7, 2002, ProtoKinetix's market cap has increased from 60.38K to 3.15M, an increase of 5,122.99%. That is a compound annual growth rate of 17.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 3.15M | 29.50% |
| Dec 31, 2025 | 2.43M | -34.52% |
| Dec 31, 2024 | 3.72M | -43.47% |
| Dec 29, 2023 | 6.58M | -22.09% |
| Dec 30, 2022 | 8.44M | -71.61% |
| Dec 31, 2021 | 29.74M | 5.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GPL Holdings | 4.17M |
| Galera Therapeutics | 3.55M |
| Vaxxinity | 3.17M |
| Oncology Pharma | 3.09M |
| Burzynski Research Institute | 2.98M |
| CASI Pharmaceuticals | 2.93M |
| Clearside Biomedical | 2.67M |
| Vaccinex | 2.38M |